Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials

Published:2017-10-17 Issue:10 Volume:14 Page:e1002410
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Basu Sanjay^ORCID,Sussman Jeremy B.^ORCID,Rigdon Joseph^ORCID,Steimle Lauren^ORCID,Denton Brian T.,Hayward Rodney A.

Funder

National Center on Minority Health and Health Disparities

National Institute on Minority Health and Health Disparities

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Center for Integrated Healthcare, U.S. Department of Veterans Affairs

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference31 articles.

1. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs;S Bromfield;Curr Hypertens Rep,2013

2. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015;MH Forouzanfar;JAMA,2017

3. A randomized trial of intensive versus standard blood-pressure control;N Engl J Med,2015

4. Effects of intensive blood-pressure control in type 2 diabetes mellitus;N Engl J Med,2010

5. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis;X Xie;Lancet,2016

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporating Individual‐Level Treatment Effects and Outcome Preferences Into Personalized Blood Pressure Target Recommendations;Journal of the American Heart Association;2024-08-20

2. The potential benefit of statin prescription based on prediction of treatment responsiveness in older individuals: an application to the PROSPER randomized controlled trial;European Journal of Preventive Cardiology;2023-12-12

3. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

4. Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults;American Journal of Hypertension;2023-06-28

5. Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches;BMC Medical Research Methodology;2023-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3